Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.8 USD | +0.52% | +8.86% | -11.86% |
05-08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
05-07 | Transcript : Pacira BioSciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.86% | 1.38B | |
+32.92% | 698B | |
+26.51% | 568B | |
-4.53% | 358B | |
+19.38% | 328B | |
+3.60% | 283B | |
+16.34% | 238B | |
+6.68% | 203B | |
-9.08% | 198B | |
+8.75% | 165B |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Earnings Flash (PCRX) PACIRA BIOSCIENCES Posts Q4 EPS $0.89, vs. Street Est of $0.85